MULTIPLE SCLEROSIS OUTCOME AND MORBI-MORTALITY OF A BRAZILIAN COHORT PATIENTS

被引:8
|
作者
Alves-Leon, Soniza Vieira [1 ,2 ,3 ,4 ]
Malfetano, Fabiola Rachid [5 ]
Veluttini Pimentel, Maria Lucia [6 ]
Duque Estrada, Claudio Luiz [7 ]
Santa Rita Pereira, Valeria Coelho [7 ]
Liem, Assuncion Martinez [7 ]
Pereira Novis, Sergio Augusto [8 ]
机构
[1] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Setor Doencas Desmielinizantes, BR-21941913 Rio De Janeiro, Brazil
[2] Univ Fed Estado Rio de Janeiro, Disciplina Neurol, Rio De Janeiro, Brazil
[3] Univ Fed Estado Rio de Janeiro, Programa Posgrad Strictu Senso Neurol, Rio de Janeiro, Brazil
[4] Univ Fed Rio de Janeiro, Programa Clin Med Neurol, Rio De Janeiro, Brazil
[5] Mestre Pela UFRJ, Hosp Naval Marcilio Dias, Rio De Janeiro, Brazil
[6] Doutora Pela UFRJ, Rio De Janeiro, Brazil
[7] Univ Fed Rio de Janeiro, Fac Med, Programa Posgrad Clin Med Neurol, Rio de Janeiro, Brazil
[8] Univ Fed Rio de Janeiro, HUCFF, Serv Neurol, Rio de Janeiro, Brazil
关键词
multiple sclerosis; mortality; morbidity; epidemiology; Brazil;
D O I
10.1590/S0004-282X2008000500012
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We studied the clinical and evolution characteristics of multiple sclerosis (MS) patients followed since the onset of HUCFF/UFRJ in 1978. The diagnosis of MS was based on Poser's et al. and MC Donald's et al. criteria. From 188 patients, 122 were included. Eighty-five were females. The mean age onset was 32.2 years-old (range 6.0 to 61.0 +/- 10.3), mainly Caucasians (82/67%). The relapsing-remitting course (MSRR) was more frequent (106/86.8%). Monosymptomatic onset was significantly more frequent in Caucasians than in Afro-Brazilians (p<0.05). Seventeen patients had benign form of MS and these patients presented association with MSRR when compared with severe form (p=0.01). The mortality rate was 2.12% (4 patients died). This study was similar to other Brazilian series with regard to sex and age, and lack of correlation between EDSS and number of relapses; it confirmed south-southeast African-descendants gradient distribution and association between first mono-symptomatic relapses and Caucasian; we found lower frequency of benign forms.
引用
收藏
页码:671 / 677
页数:7
相关论文
共 50 条
  • [31] Activity and morbi-mortality of coronary artery by-pass surgery in Spain
    Pons, JMV
    Saura, E
    Pomar, JL
    REVISTA ESPANOLA DE CARDIOLOGIA, 1998, 51 : 114 - 129
  • [32] Safety culture in intensive care in france: is there a link with morbi-mortality conferences?
    C Bretonnière
    C Guitton
    Intensive Care Medicine Experimental, 3 (Suppl 1)
  • [33] Morbi-mortality after recovery from cancer in childhood: Review of literature
    Contant, Pierre
    Goldschmidt, Charlotte Demoor
    Mallebranche, Coralie
    Pellier, Isabelle
    BULLETIN DU CANCER, 2023, 110 (02) : 225 - 232
  • [34] Incidence and clinical outcome of COVID-19 in a cohort of 11.560 Brazilian patients with multiple sclerosis
    Mendes, M. F.
    Ferreira, M. L.
    Sousa, N. A.
    Thomaz, R.
    Apostolos-Pereira, S. L.
    Alves-Leon, S.
    Piccolo, A. C.
    De Oliveira, E. M.
    Vasconcelos, C. C.
    Muniz, A.
    Gomes Neto, A.
    De Oliveira, B. E.
    Da Rocha, F.
    Martins, G.
    Dos Santos, G. A.
    Ruocco, H. H.
    Soares Neto, H.
    De Vecino, M. C.
    Boaventura, M.
    Dias, R. M.
    Gomes, S.
    Castro, A.
    D'Almeida, J. A.
    Rocha, L.
    Pimentel, M. L.
    Pitombeira, M.
    Arambula, O.
    Pereira, V.
    Cabeca, H.
    Goncalves, M. V.
    Dias-Carneiro, R.
    Ferreira, L.
    Guimaraes, R.
    Fortaleza, C. M.
    Diniz, D.
    Grzesiuk, A.
    Kaimen-Maciel, D. R.
    Comini-Frota, E.
    Do Olival, G.
    Siqueira, H. H.
    Sato, H.
    Calia, L.
    Melges, L. D.
    Dourado Junior, M. E.
    Ribeiro, M.
    Sousa, M. A.
    Parolin, M.
    Da Gama, P.
    Morales, R.
    Sobreira, S.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 95 - 97
  • [35] JIKEI HEART Study—A Morbi-Mortality and Remodeling Study with Valsartan in Japanese Patients with Hypertension and Cardiovascular Disease
    Seibu Mochizuki
    Mitsuyuki Shimizu
    Ikuo Taniguchi
    Kiyoshi Kanae
    Satoru Yoshida
    Naoko Tajima
    Bjorn Dahlöf
    Cardiovascular Drugs and Therapy, 2004, 18 : 305 - 309
  • [36] RELATED FACTORS TO PERINATAL MORBI-MORTALITY .5. OBSTETRICAL ANTECEDENTS
    CLAVEROSALVADOR, PA
    RODRIGUEZDEISLASANCHEZ, JL
    FERNANDEZ, TG
    VILLARREALALCARAZ, A
    SANCHIS, SM
    ACTA GINECOLOGICA, 1978, 32 (10): : 325 - 333
  • [37] Effects of preceding stable or unstable angina on hospital morbi-mortality of myocardial infarction
    Fichaux, O
    Pacouret, G
    Djeffal-Vincentelli, D
    Hamel, E
    Peycher, P
    Maillard, L
    Charbonnier, B
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 2002, 95 (02): : 87 - 92
  • [38] Can regression of LVH be proposed as a substitute criterion in trials of morbi-mortality in hypertension?
    Gosse, P
    Herpin, D
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 2000, 93 (11): : 1435 - 1440
  • [39] Hyponatremia and hypoalbuminemia are predictors of morbi-mortality in coronary artery bypass graft surgery
    Aydinli, Bahar
    Bolukbasi, Demet
    Demir, Asli
    Guclu, Cigdem Yildirim
    Koculu, Rabia
    KUWAIT MEDICAL JOURNAL, 2019, 51 (02): : 151 - 156
  • [40] Metformin: from pharmacovigilance to medical practices improvement! A morbi-mortality review (MMR)
    Gillet, L.
    Lelavergne, S.
    Compagnon, P.
    Durand, D.
    Decreau-Gaillon, G.
    Massy, N.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 39 - 39